LEON FRANCISCO (Chief Scientific Officer) sold 1.5% of their position (24.02K shares) of PROVENTION BIO, INC. on the open market
Open‑market sale worth $246.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/20/2023ACC: 0001493152-23-002085
DirectorOfficer10% Owner· Chief Scientific Officer
Since Jul 2018
-24.02K
Net shares
Net seller
$246.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
24.02K acquired · 48.03K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+24.02K
Price / share
$2.50
Trade value
$60.04K
% of position
1.5%
1/18/2023
1.57M→1.60M
Common Stock
Direct
Shares
−24.02K
Price / share
$10.27
Trade value
$246.58K
% of position
1.5%
1/18/2023
1.60M→1.57M
Total
Net shares
+0.00
Net value
-$186.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/18/2023 | M · Option Exercise | +24.02K | $2.50 | $60.04K | 1.5% | 1.57M | 1.60M |
| Common Stock Direct | 1/18/2023 | S · Sale | −24.02K | $10.27 | $246.58K | 1.5% | 1.60M | 1.57M |
| Total | +0.00 | -$186.55K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
24.02K shares
Shares
−24.02K
Strike price
2.5
Held after
318.09K
Exercisable
—
1/18/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock24.02K shares | 1/18/2023 | M · Option Exercise | −24.02K | 2.5 | — | 318.09K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1M
Total
1M indirect1M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1M | Indirect |
| Total | 1M | 1M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported